Dr. Nicolas M. Intagliata, MD

Dr. Intagliata practices at UVA University Medical Center in Charlottesville, Virginia.

Dr. Intagliata's NPI, 1043413768, was assigned on June 8, 2007. Dr. Intagliata graduated from Wake Forest University School of Medicine in 2007. Dr. Intagliata holds Virginia license 0101251316.

Dr. Intagliata's primary practice is UVA University Medical Center, at 1215 Lee St, Charlottesville, VA 22908 in Charlottesville City. The practice phone is (434) 760-3439.

Dr. Intagliata's primary practice is UVA University Medical Center in Charlottesville, Virginia. Dr. Intagliata is also affiliated with University Medical Center. The medical group on file is UVA Physicians Group. Dmand AI also links Dr. Intagliata to 4 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Intagliata practices, 6 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Intagliata's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Intagliata is licensed in Virginia.

CMS data shows 607 Medicare services from Dr. Intagliata across 11 procedure codes in 2024, for 320 Medicare patients. Medicare paid $33,114 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 320 Medicare patients who saw Dr. Intagliata in 2024. The largest group is 65 to 74, with 173 patients. 75% of them have high blood pressure, and 66% have high cholesterol. 10% are also on Medicaid. Their average risk score is 2.18, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Intagliata's median patient age at 61, with 49% women.

In 2024, Dr. Intagliata wrote 1,611 Medicare Part D claims for 258 patients. 91% of them were for generic drugs. CMS names the drug for 1,394 of them, across 25 drugs with 11 or more claims each, at $347,814 in total drug cost. In 2023, CMS named 1,140 claims across 25 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Intagliata for performance year 2024, reported as part of a group. Dr. Intagliata accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Intagliata as offering telehealth. CMS counts 55 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Intagliata, more than 65% of the clinicians it reports for that procedure.

Dmand AI links 53 papers to Dr. Intagliata, published from 2010 to 2024. 2018 was the busiest year, with 7. The most frequent topics are Liver Cirrhosis, Hemorrhage and Anticoagulants. Dr. Intagliata has published most often in Clin Liver Dis (Hoboken). Dr. Intagliata's most frequent co-authors are Stephen H. Caldwell, Curtis K. Argo, MD and Jonathan Gibson Stine, MD.

Dr. Intagliata graduated from Wake Forest University School of Medicine in 2007.